Bellerophon Therapeutics (BLPH) Reports Q3 Loss of $0.37/Share
Tweet
Share
E-mailGet Alerts BLPH Hot Sheet
Join SI Premium – FREE
Bellerophon Therapeutics (NASDAQ: BLPH) reported Q3 EPS of ($0.37), versus ($0.83) reported last year.
For earnings history and earnings-related data on Bellerophon Therapeutics (BLPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
